Proteomics of serum exosomes identified fibulin-1 as a novel biomarker for mild cognitive impairment

Proteomics of serum exosomes identified fibulin-1 as a novel biomarker for mild cognitive impairment

Mild cognitive impairment (MCI) is a prodrome of Alzheimer’s disease pathology. Cognitive impairment patients often have a delayed diagnosis because there are no early symptoms or conventional diagnostic methods. Exosomes play a vital role in cell-to-cell communications and can act as promising biom...

Full description

Bibliographic Details
Main Authors: Bo Chen, Li Song, Juan Yang, Wei-Ying Zhou, Yuan-Yuan Cheng, Yu-Jie Lai
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2023-01-01
Series:Neural Regeneration Research
Subjects:
alzheimer’s disease; biomarker; diagnosis; exosomes; fibulin; mass spectrometry; mild cognitive impairment; tandem mass tag; cell adhesion molecule; nanoparticle tracking analysis
Online Access:http://www.nrronline.org/article.asp?issn=1673-5374;year=2023;volume=18;issue=3;spage=587;epage=593;aulast=Chen

Internet

http://www.nrronline.org/article.asp?issn=1673-5374;year=2023;volume=18;issue=3;spage=587;epage=593;aulast=Chen

Similar Items